Abstract:Background Hepatocellular carcinoma (HCC) is the second-highest cause of malignancy-related death worldwide, and many physiological and pathological processes, including cancer, are regulated by microRNAs (miRNAs). miR-193a-3p is an anti-oncogene that plays an important part in health and disease biology by interacting with specific targets and signals. Methods In vitro assays were performed to explore the influences of miR-193a-3p on the propagation and apoptosis of HCC cells. The sequencing data for HCC were obtained from The Cancer Genome Atlas (TCGA), and the expression levels of miR-193a-3p in HCC and non-HCC tissues were calculated. The differential expression of miR-193a-3p in HCC was presented as standardized mean difference (SMD) with 95% confidence intervals (CIs) in Stata SE. The impact of miR-193a-3p on the prognoses of HCC patients was determined by survival analysis. The potential targets of miR-193a-3p were then predicted using miRWalk 2.0 and subjected to enrichment analyses, including Gene Ontology (GO) annotation, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, and Protein-Protein Interaction (PPI) network analysis. The interaction between miR-193a-3p and one predicted target, Cyclin D1 (CCND1), was verified by dual luciferase reporter assays and Pearson correlation analysis. Results MiR-193a-3p inhibited the propagation and facilitated the apoptosis of HCC cells in vitro. The pooled SMD indicated that miR-193a-3p had a low level of expression in HCC (SMD: −0.88, 95% CI [−2.36 −0.59]). Also, HCC patients with a higher level of miR-193a-3p expression tended to have a favorable overall survival (OS: HR = 0.7, 95% CI [0.43–1.13], P = 0.14). For the KEGG pathway analysis, the most related pathway was “proteoglycans in cancer”, while the most enriched GO term was “protein binding”. The dual luciferase reporter assays demonstrated the direct interaction between miR-193a-3p and CCND1, and the Pearson correlation analysis suggested that miR-193a-3p was negatively correlated with CCND1 in HCC tissues (R = − 0.154, P = 0.002). Conclusion miR-193a-3p could suppress proliferation and promote apoptosis by targeting CCND1 in HCC cells. Further, miR-193a-3p can be used as a promising biomarker for the diagnosis and treatment of HCC in the future.

MiR‐199a‐5p Suppresses Tumorigenesis by Targeting Clathrin Heavy Chain in Hepatocellular Carcinoma

MiR-148b Suppresses Cell Proliferation and Invasion in Hepatocellular Carcinoma by Targeting WNT1/β-catenin Pathway

MicroRNA-302d Downregulates TGFBR2 Expression and Promotes Hepatocellular Carcinoma Growth and Invasion.

MiR-875-5p suppresses Gli1 to alter the hedgehog signaling pathway, which in turn has hepatocellular cancer-related tumor suppressing properties

Mir-200A Suppresses Cell Growth and Migration by Targeting MACC1 and Predicts Prognosis in Hepatocellular Carcinoma.

Downregulation of Mir-193A-3p is Involved in the Pathogenesis of Hepatocellular Carcinoma by Targeting CCND1

Microrna-519 Suppresses Cell Growth And Invasion By Reducing Hur Levels In Hepatocellular Carcinoma

Downregulation of Mir-199A-3p in Hepatocellular Carcinoma and Its Relevant Molecular Mechanism Via GEO, TCGA Database and in Silico Analyses

MiR-3934-5p promotes proliferation of hepatocellular carcinoma cells by targeting LACTB

MicroRNA-99a Inhibits Hepatocellular Carcinoma Growth and Correlates with Prognosis of Patients with Hepatocellular Carcinoma

Identification of MiR-211-5p as a tumor suppressor by targeting ACSL4 in Hepatocellular Carcinoma

MicroRNA-1405 p suppresses tumor growth and metastasis by targeting TGFBR 1 and FGF 9 in Hepatocellular carcinoma

MiR-199a Regulates Cell Proliferation and Survival by Targeting FZD7

MicroRNA-195 Suppresses Tumorigenicity and Regulates G1/S Transition of Human Hepatocellular Carcinoma Cells.

miR-885-5p suppresses hepatocellular carcinoma metastasis and inhibits Wnt/β-catenin signaling pathway

MicroRNA-181c suppresses growth and metastasis of hepatocellular carcinoma by modulating NCAPG

MicroRNA-195 acts as a tumor suppressor by directly targeting Wnt3a in HepG2 hepatocellular carcinoma cells.

MiR-875-5p Inhibits Hepatocellular Carcinoma Cell Proliferation and Migration by Repressing Astrocyte Elevated Gene-1 (AEG-1) Expression

MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma.

MiR-299-3p Functions As a Tumor Suppressor Via Targeting Sirtuin 5 in Hepatocellular Carcinoma

Downregulation of Mir-136-5p in Hepatocellular Carcinoma and Its Clinicopathological Significance